Park Avenue Securities’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-27,869
Closed -$444K 1530
2025
Q3
$444K Buy
+27,869
New +$459K ﹤0.01% 1241

Other funds holding BTAL

Park Avenue Securities's BTAL Position: Q4 2025 in Review

Park Avenue Securities sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2025, closing a stake of 27,869 shares — an estimated $444K sold.

Park Avenue Securities first reported a position in BTAL in Q3 2025 and held it in 1 quarter. The position peaked at $444K in Q3 2025. 81 funds tracked by Wall St. Rank hold BTAL as of Q4 2025.

  • Park Avenue Securities reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2025 after selling out during the quarter.
  • Park Avenue Securities sold 27,869 AGF US Market Neutral Anti-Beta Fund shares in Q4 2025, an estimated $444K.
  • Park Avenue Securities first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2025 and held it in 1 quarter.
  • Park Avenue Securities's AGF US Market Neutral Anti-Beta Fund position peaked at $444K in Q3 2025.
  • 81 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2025.

Based on Park Avenue Securities's 13F filing for Q4 2025, filed 5 Jan 2026.